HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Roy, D. M. Articles by Emery, V. C. Search for Related Content PubMed PubMed Citation Articles by Roy, D. M. Articles by Emery, V. C. Agricola Articles by Roy, D. M. Articles by Emery, V. C.

Sequence variation within neutralizing epitopes of the envelope glycoprotein B of human cytomegalovirus: comparison of isolates from renal transplant recipients and AIDS patients

Donna M. Roy

Jane E. Grundy

Division of Communicable Diseases, Royal Free Hospital School of Medicine, Rowland Hill Street, Hampstead, London NW3 2QG, U.K.

The envelope glycoprotein B of human cytomegalovirus (CMV) is a major target of the neutralizing antibody response against this virus, and hence has importance as a potential subunit vaccine. PCR was utilized to amplify DNA encoding the dominant antigenic determinant on this molecule, AD-1 (codons 552 to 635), and DNA sequencing was carried out in order to compare nucleotide variation in AD-1 between clinical isolates of CMV and the laboratory strain AD169. Wild-type CMV strains isolated from AIDS patients were not only more likely to possess nucleotide substitutions (19/24 compared to 5/25, P < 0·0001) than those from renal transplant recipients, but they also exhibited a greater degree of nucleotide sequence divergence (6·94 versus 0·82 substitutions/1000 bp, P < 0·0001; 96·0 to 100% versus 99·4 to 100% similarity). Increased sequence variation in the AIDS patients did not correlate with absolute peripheral blood CD4⁺ T cell level (r = 0·33, P > 0·1). Only two strains from AIDS patients and one strain from the renal transplant recipients possessed nucleic acid substitutions that resulted in codon changes, indicating that AD-1 is relatively well conserved amongst clinical isolates of CMV. The demonstration of strains with codon changes within neutralizing epitopes, however, highlights the importance of taking into consideration the presence of these strains within the wildtype virus population when preparing subunit vaccines.

Present address: Dept. of Clinical Immunology, Royal Free Hospital School of Medicine, Rowland Hill Street, Hampstead, London NW3 2QG, U.K.

Received 8 April 1993; accepted 16 July 1993.

This article has been cited by other articles:

				M. R. Auerbach, S. C. Czajak, W. E. Johnson, R. C. Desrosiers, and L. Alexander Species Specificity of Macaque Rhadinovirus Glycoprotein B Sequences J. Virol., January 1, 2000; 74(1): 584 - 590. [Abstract] [Full Text]

				A. Speckner, D. Glykofrydes, M. Ohlin, and M. Mach Antigenic domain 1 of human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralization J. Gen. Virol., August 1, 1999; 80(8): 2183 - 2191. [Abstract] [Full Text]

				R. P. Searles, E. P. Bergquam, M. K. Axthelm, and S. W. Wong Sequence and Genomic Analysis of a Rhesus Macaque Rhadinovirus with Similarity to Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 J. Virol., April 1, 1999; 73(4): 3040 - 3053. [Abstract] [Full Text]